IRIS Accounts Production v22.1.0.628 11045710 Board of Directors 1.1.21 31.12.21 31.12.21 8/9/2022 0 false true false false true false Auditors Opinion Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure110457102020-12-31110457102021-12-31110457102021-01-012021-12-31110457102019-12-31110457102020-01-012020-12-31110457102020-12-3111045710ns16:EnglandWales2021-01-012021-12-3111045710ns15:PoundSterling2021-01-012021-12-3111045710ns11:Director12021-01-012021-12-3111045710ns11:PrivateLimitedCompanyLtd2021-01-012021-12-3111045710ns11:SmallEntities2021-01-012021-12-3111045710ns11:Audited2021-01-012021-12-3111045710ns11:SmallCompaniesRegimeForDirectorsReport2021-01-012021-12-3111045710ns11:SmallCompaniesRegimeForAccounts2021-01-012021-12-3111045710ns11:FullAccounts2021-01-012021-12-3111045710ns11:OrdinaryShareClass12021-01-012021-12-3111045710ns11:Director22021-01-012021-12-3111045710ns11:RegisteredOffice2021-01-012021-12-3111045710ns6:CurrentFinancialInstruments2021-12-3111045710ns6:CurrentFinancialInstruments2020-12-3111045710ns6:ShareCapital2021-12-3111045710ns6:ShareCapital2020-12-3111045710ns6:RetainedEarningsAccumulatedLosses2021-12-3111045710ns6:RetainedEarningsAccumulatedLosses2020-12-3111045710ns11:OrdinaryShareClass12021-12-31
REGISTERED NUMBER: 11045710 (England and Wales)










FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2021

FOR

HEALTH CATALYST UK LTD

HEALTH CATALYST UK LTD (REGISTERED NUMBER: 11045710)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2021




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


HEALTH CATALYST UK LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2021







DIRECTORS: J L Alger
D H Orenstein





REGISTERED OFFICE: Suite 2 First Floor
10 Temple Back
Bristol
United Kingdom
BS1 6FL





REGISTERED NUMBER: 11045710 (England and Wales)





AUDITORS: Mark Arber Limited
Statutory Auditors
71-75 Shelton Street
Covent Garden
London
WC2H 9JQ

HEALTH CATALYST UK LTD (REGISTERED NUMBER: 11045710)

BALANCE SHEET
31 DECEMBER 2021

2021 2020
Notes £    £   
CURRENT ASSETS
Debtors 4 11,659 100

CREDITORS
Amounts falling due within one year 5 (5,595 ) -
NET CURRENT ASSETS 6,064 100
TOTAL ASSETS LESS CURRENT
LIABILITIES

6,064

100

CAPITAL AND RESERVES
Called up share capital 6 100 100
Retained earnings 5,964 -
SHAREHOLDERS' FUNDS 6,064 100

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 8 September 2022 and were signed on its behalf by:





J L Alger - Director


HEALTH CATALYST UK LTD (REGISTERED NUMBER: 11045710)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2021

1. STATUTORY INFORMATION

Health Catalyst UK Ltd is a private company, limited by shares, registered in England & Wales. The company's registered number and registered office can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Share based payments
The company participates in a group equity settled share based payment arrangement granted to its employees. The group has elected to recognise and measure its share-based payment expense by specifically calculating the expense at a subsidiary level. The calculation is based on the number of employee options which have vested during the period.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2020 - NIL ) .

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2021 2020
£    £   
Amounts owed by group undertakings 11,659 100

HEALTH CATALYST UK LTD (REGISTERED NUMBER: 11045710)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2021

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2021 2020
£    £   
Taxation and social security 4,145 -
Other creditors 1,450 -
5,595 -

6. CALLED UP SHARE CAPITAL


Allotted, issued and fully paid:
Number: Class: Nominal 2021 2020
value: £    £   
100 Ordinary 1 100 100

7. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Mark Arber (Senior Statutory Auditor)
for and on behalf of Mark Arber Limited

8. RELATED PARTY DISCLOSURES

The company has taken the exemption provided by FFRS 102 Section 33.1A not to disclose related party transactions with wholly owned subsidiaries within the group.

9. SHARE-BASED PAYMENT TRANSACTIONS

The company has taken the exemption provided in FRS 102 Section 1.12D not to disclose details of share-based payment arrangements concerning equity instruments of another group entity.

10. ULTIMATE CONTROLLING PARTY

Health Catalyst, Inc. (incorporated in the United States of America) is regarded by the directors as being the Company's ultimate parent company.

The largest and smallest group in which the results of the company are consolidated is that headed by Health Catalyst, Inc., a company incorporated in the United States of America. The address of Health Catalyst, Inc., is 10897 S River Front Parkway Suite 300, South Jordan, UT- 84095, U.S.A.